Pinned Tweet
Replying to @IACytology
@IACytology @AshishC97225686
Thank Ash and Gary for hosting the IAC webinar. Allison and Carmen kindly helped the recording. I'm really thankful for over 200 online participants for those two talks. Grateful for the opportunity of doing contribution.
youtu.be/8v4-heveFio?si=316D…
Mark CC Chen, M.D. FIAC retweeted
Join the #SLAC companion meeting #ECCyto2026 in Antwerp @citologiala
Sharing exper and strengthening academic ties 🌏📚🔬@milyabadli @Zoroquiainp @FridaRosenblum @MauroSaieg @MerceJorda1 @CeciliaEGimene1 @CDinares @SECitologia @MozeticV @CytologyEFCS @EfcsYoung
#cytology
This is very helpful and interesting. – at Tainan City, Taiwan
⚡#OpenAccess! Validation of on-slide immunocytochemistry controls prepared from long-term preserved prefixed cell suspensions
acsjournals.onlinelibrary.wi…
#CytoPath
Mark CC Chen, M.D. FIAC retweeted
Pelvic washing containing a metastatic high grade gynecologic malignancy. What cytologic preparation was used? Answer: buff.ly/3MZzIdG
#PathTwitter #CytoPath #Cytology #PathArt #Pathology
Mark CC Chen, M.D. FIAC retweeted
Replying to @PapSociety
@PapSociety Companion Meeting #ECCyto2026
Like a Box of Chocolates: Navigating Surprises in Cytology 🍫 Chairs: @DianaEstherossi @aakasharmand
🧩 Build your diagnostic strategy 🧠
🔬 Take home tools for your everyday practice 👀
#Cytology #Cytopath @PoonamVohra3
Ready to unwrap some diagnostic surprises in cytology?
Join us at the @PapSociety Companion Meeting at the 46th European Congress of Cytology in Antwerp! @PoonamVohra3 @DianaEstherossi @aakasharmand @AzizaNassar2 @mdlozanoe #ECCyto2026
Mark CC Chen, M.D. FIAC retweeted
#IACwebinar
Join us this Friday, 25 September 2026 for:
“Pancreatic #Cytopathology: New WHO Classification — An Update”
🎙️ Asif Loya, MD
🕑 2:00 PM CEST | 5:00 PM PKT
🔒 IAC members only — pre-registration required.
#Pancreas #WHOClassification #Pathology #EUSFNAC
Mark CC Chen, M.D. FIAC retweeted
Neutrophil-calibrated atypical squamous cells in ThinPrep urine cytology for detecting squamous differentiation in urothelial carcinoma
acsjournals.onlinelibrary.wi…
#CytoPath
Mark CC Chen, M.D. FIAC retweeted
🔬 Free access | Diagnostic challenges in urinary cytology: Practical insights from The Paris System for Reporting Urinary Cytology
acsjournals.onlinelibrary.wi…
#CytoPath #ParisSystem @cjvand
Nature review: Molecular mechanisms and pathogenesis of MASH
go.nature.com/4i5T1V3
Mark CC Chen, M.D. FIAC retweeted
New publication in Cancer Cytopathology! 🎉🇫🇮🇨🇿
Our Finnish–Czech collaboration on rare primary pulmonary salivary gland-type tumors: overall cytohistologic concordance 48.1%, with FNA performing best (75%).
Many thanks to Henri Lagerstam & Ivana Kholová doi.org/10.1002/cncy.70153 – at Horoměřice, Česká republika
Let's join the survey. I completed the survey right after I got the email.
Dear cytologists/cytopathologists
The American Society of Cytopathology needs to hear from you! Please fill out this important survey on the impact of the CMS memorandum on digital cytology
👉 surveymonkey.com/r/3QQJLXJ
#CytoPath #Cytopathology #Pathology #Pathologists
Our paper is out in @Cancer_Cell!
We started this project almost 5 years ago with the idea that to understand why some cancer patients respond to immunotherapy and others do not, we may need to look beyond the tumor before treatment. Immunotherapy is not just a test of a pre-existing state; it is a perturbation. It changes the tumor immune microenvironment.
So the question became: can the direction of that change explain response?
authors.elsevier.com/a/1niWC…
Mark CC Chen, M.D. FIAC retweeted
Review: Decoding T cell exhaustion in the tumour microenvironment
nature.com/articles/s12276-0…
Mark CC Chen, M.D. FIAC retweeted
📢 Beyond the adult standard: Tailoring the WHO Reporting System for Lymph Node Cytopathology to pediatric diagnostics and management
acsjournals.onlinelibrary.wi…
#CytoPath CC: @IvanaKholova
Mark CC Chen, M.D. FIAC retweeted
#OpenAccess | Malignant effusions secondary to metastatic thyroid carcinomas: A review of 15 cases. Ancillary testing is extremely helpful in arriving at the correct diagnosis.
acsjournals.onlinelibrary.wi…
#CytoPath CC: @Sinchita_Roy
Interobserver variability does not explain the limited predictive value of PD-L1 TPS in the neoadjuvant setting. PD-L1 has an intrinsic limitation.
sciencedirect.com/science/ar…
Mark CC Chen, M.D. FIAC retweeted
Biomarker-Driven Management of Nonmetastatic GEJ Adenocarcinoma @annsurgoncol link.springer.com/article/10…
Mark CC Chen, M.D. FIAC retweeted
🤔 Once in a career, you may encounter a pleural effusion case like this. When that moment comes, you'll be glad you've seen it before in the literature. #Cytopath #CytoJ ⬇️
doi.org/10.1111/cyt.70108































